|
Referenz |
Lieferant |
Beschreibung |
Einheit |
Preis exkl. MwSt. |
|
|
|
USP-1445608 |
USP |
Moexipril Related Compound A 20 mg |
|
865.33 CHF
940.61 €
|
|
|
|
USP-1445619 |
USP |
Moexipril Related Compound B - ((S)-ethyl 2-{(3S,11aS)-8,9-dimethoxy-3-methyl-1,4-dioxo-3,4-dihydro-1H 20 mg |
|
617.33 CHF
671.04 €
|
|
|
|
USP-1445620 |
USP |
Moexipril Related Compound C (20 mg) ((S)-tert-butyl 2-{(S)-2-[(S)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino]propanoyl}-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylate, maleate) 20 mg |
|
617.33 CHF
671.04 €
|
|
|
|
USP-1445631 |
USP |
Moexipril Related Compound D - ((S)-2-{(S)-2-[(S)-4-cyclohexyl-1-ethoxy-1-oxobutan-2-ylamino]propanoyl 20 mg |
|
617.33 CHF
671.04 €
|
|
|
|
USP-1445642 |
USP |
Moexipril Related Compound E - ((S)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, hy 20 mg |
|
617.33 CHF
671.04 €
|
|
|
|
USP-1445653 |
USP |
Moexipril Related Compound F 20 mg |
|
1,746.67 CHF
1,898.63 €
|
|
|
|
USP-1445664 |
USP |
Moexipril Related Compound G - ((S)-6,7-dimethoxy-2-{(S)-2-[(S)-1-methoxy-1-oxo-4-phenylbutan-2-ylamino]propanoyl}-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, hydrochloride) 20 mg |
|
617.33 CHF
671.04 €
|
|
|
|
USP-1445925 |
USP |
Monoethanolamine 1 mL |
|
533.33 CHF
579.73 €
|
|
|
|
USP-1446000 |
USP |
Monoglycerides 125 mg |
|
438.67 CHF
476.83 €
|
|
|
|
USP-1446600 |
USP |
Monosodium Glutamate 500 mg |
|
868.00 CHF
943.52 €
|
|
|
|
USP-1446804 |
USP |
Monostearyl Maleate 100 mg |
|
1,589.33 CHF
1,727.60 €
|
|
|
|
USP-1446815 |
USP |
Montelukast Dicyclohexylamine 150 mg |
|
1,566.67 CHF
1,702.97 €
|
|
|
|
USP-1446837 |
USP |
Montelukast for Peak Identification (Mixture of montelukast dicyclohexylamine (91.7%), sulfoxide impurity (0.3%), Michael adducts 1 and 2 impurity (2.5%), methylketone impurity (2.7%), and methylstyrene impurity (1.6%)) 20 mg |
|
1,604.00 CHF
1,743.55 €
|
|
|
|
USP-1446848 |
USP |
Montelukast Racemate - BACKORDER 20 mg |
|
1,604.00 CHF
1,743.55 €
|
|
|
|
USP-1446859 |
USP |
Montelukast Sodium (Sodium 1-[[[(R)-m-[(E)-2-(7-chloro-2-quinolyl)vinyl]-alpha-[o-(1-hydroxy-1-methylethyl)phenethyl]benzyl]thio]methyl]cyclopropaneacetate) 50 mg |
|
492.00 CHF
534.80 €
|
|
|
|
USP-1446906 |
USP |
Morantel Tartrate 100 mg |
|
456.00 CHF
495.67 €
|
|
|
|
USP-1446950 |
USP |
Moricizine Hydrochloride (HCl) 250 mg |
|
586.67 CHF
637.71 €
|
|
|
|
USP-1448559 |
USP |
Moxidectin (200 mg) 200 mg |
|
761.33 CHF
827.57 €
|
|
|
|
USP-1448560 |
USP |
Moxidectin System Suitability Mixture 50 mg |
|
1,650.67 CHF
1,794.28 €
|
|
|
|
USP-1448606 |
USP |
Moxifloxacin Hydrochloride ((1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3- quinolinecarboxylic acid, monohydrochloride monohydrate)) 200 mg |
|
1,208.00 CHF
1,313.10 €
|
|
|
|
USP-1448617 |
USP |
Moxifloxacin Related Compound A - 1-cyclopropyl-6,8-difluoro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid 25 mg |
|
1,568.00 CHF
1,704.42 €
|
|
|
|
USP-1448628 |
USP |
Moxifloxacin Related Compound B (25 mg) - (1-Cyclopropyl-6,8-dimethoxy-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride monohydrate) 25 mg |
|
1,648.00 CHF
1,791.38 €
|
|
|
|
USP-1448639 |
USP |
Moxifloxacin Related Compound C (25 mg) (1-Cyclopropyl-8-ethoxy-6-fluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride monohydrate) 25 mg |
|
1,648.00 CHF
1,791.38 €
|
|
|
|
USP-1448640 |
USP |
Moxifloxacin Related Compound D (1-Cyclopropyl-8-fluoro-6-methoxy-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid) 15 mg |
|
1,568.00 CHF
1,704.42 €
|
|
|
|
USP-1448655 |
USP |
Moxifloxacin Related Compound E (25 mg) (1-Cyclopropyl-6-fluoro-8-hydroxy-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride) 25 mg |
|
1,529.33 CHF
1,662.38 €
|
|
|
|
USP-1448661 |
USP |
Moxifloxacin Related Compound F - (1-Cyclopropyl-6-fluoro-8-methoxy-7-(1-methyloctahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid) 25 mg |
|
1,529.33 CHF
1,662.38 €
|
|
|
|
USP-1448672 |
USP |
Moxifloxacin Related Compound G (15 mg) (1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid, monohydrochloride) 15 mg |
|
1,728.00 CHF
1,878.34 €
|
|
|
|
USP-1448854 |
USP |
Low Molecular Weight Heparin Molecular Weight Calibrant (10.6 mg) - Biologic 10,6 mg |
|
1,529.33 CHF
1,662.38 €
|
|
|
|
USP-1448901 |
USP |
Mupirocin 50 mg |
|
492.00 CHF
534.80 €
|
|
|
|
USP-1448912 |
USP |
Mupirocin Calcium 200 mg |
|
629.33 CHF
684.08 €
|
|
|
|
USP-1448923 |
USP |
Mupirocin Lithium 100 mg |
|
594.67 CHF
646.41 €
|
|
|
|
USP-1448956 |
USP |
Mycophenolate Mofetil 200 mg |
|
492.00 CHF
534.80 €
|
|
|
|
USP-1448967 |
USP |
Mycophenolate Mofetil Related Compound A - 2-morpholinoethyl-(E)-6-(1,3-dihydro-4,6-dihydroxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate 15 mg |
|
1,568.00 CHF
1,704.42 €
|
|
|
|
USP-1448978 |
USP |
Mycophenolate Mofetil Related Compound B [(RS)-7-hydroxy-5-methoxy-4-methyl-6-[2-(5-methyl-2-oxo-tetrahydrofuran-5-yl)ethyl]-3H-isobenzofuranyl-1-one] 15 mg |
|
1,568.00 CHF
1,704.42 €
|
|
|
|
USP-1448989 |
USP |
Mycophenolate Sodium (Sodium (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methylhex-4-enoate) 200 mg |
|
492.00 CHF
534.80 €
|
|
|
|
USP-1448990 |
USP |
Myristic Acid 200 mg |
|
512.00 CHF
556.54 €
|
|
|
|
USP-1449008 |
USP |
Myristyl Alcohol 5 x 100 mg |
|
512.00 CHF
556.54 €
|
|
|
|
USP-1449041 |
USP |
Myristylpyridinium Chloride (1-Tetradecylpyridinium chloride) 25 mg |
|
620.00 CHF
673.94 €
|
|
|
|
USP-1449518 |
USP |
Nabumetone 200 mg |
|
492.00 CHF
534.80 €
|
|
|
|
USP-1449530 |
USP |
Nabumetone Related Compound A - 1-(6-methoxy-2-naphthyl)-but-1-en-3-one 15 mg |
|
1,372.00 CHF
1,491.36 €
|
|
|
|
USP-1449700 |
USP |
Nadolol 200 mg |
|
492.00 CHF
534.80 €
|
|
|
|
USP-1449711 |
USP |
Nadolol Related Compound A ((2RS,3SR)-5-(2,3-Dihydroxypropoxy)-1,2,3,4-tetrahydronaphthalene-2,3-diol) 25 mg |
|
1,372.00 CHF
1,491.36 €
|
|
|
|
USP-1449722 |
USP |
Nadolol Related Compound B ((2RS,3SR)-5-(2-Hydroxy-3-methoxypropoxy)-1,2,3,4-tetrahydronaphthalene-2,3-diol) 25 mg |
|
1,372.00 CHF
1,491.36 €
|
|
|
|
USP-1449733 |
USP |
Nadolol Related Compound C ((2SR,3RS)-5-(3-{[(6RS,7SR)-6,7-Dihydroxy-5,6,7,8-tetrahydronaphthalen-1-yl]oxy}-2-hydroxypropoxy)-1,2,3,4-tetrahydronaphthalene-2,3-diol and 1,3-Bis[(6R,7S)-6,7-dihydroxy-5,6,7,8-tetrahydronaphthalene-1-yloxy]propane-2-ol) 25 mg |
|
1,441.33 CHF
1,566.73 €
|
|
|
|
USP-1449766 |
USP |
Nadolol Related Compound F (1-(tert-Butylamino)-3-(naphthalen-1-yloxy)propan-2-ol) 25 mg |
|
1,558.67 CHF
1,694.27 €
|
|
|
|
USP-1449777 |
USP |
Nadolol Related Compound G (1-(tert-Butylamino)-3-(5,6,7,8-tetrahydronaphthalen-1-yloxy)propan-2-ol) 25 mg |
|
1,409.33 CHF
1,531.94 €
|
|
|
|
USP-1450007 |
USP |
Nafcillin Sodium 200 mg |
|
456.00 CHF
495.67 €
|
|
|
|
USP-1450018 |
USP |
Nafcillin System Suitability Mixture (This mixture contains nafcillin sodium and ethoxynaphthoic acid) 15 mg |
|
1,484.00 CHF
1,613.11 €
|
|
|
|
USP-1450404 |
USP |
Naftifine Hydrochloride ((E)-N-Cinnamyl-N-methyl-1-naphthalenemethylamine hydrochloride) 200 mg |
|
525.33 CHF
571.03 €
|
|
|
|
USP-1453005 |
USP |
Naloxone (17-Allyl-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one) - BACKORDER 200 mg |
|
416.00 CHF
452.19 €
|
|
